Filter News
Area of Research
News Type
News Topics
- (-) Coronavirus (5)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (4)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biomedical (4)
- Biotechnology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Composites (1)
- Computer Science (6)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (3)
- Environment (3)
- Fossil Energy (1)
- Frontier (1)
- Fusion (10)
- Grid (1)
- High-Performance Computing (1)
- ITER (2)
- Materials (6)
- Materials Science (14)
- Microscopy (2)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (11)
- Partnerships (2)
- Physics (7)
- Quantum Science (4)
- Security (1)
- Simulation (1)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (3)
- Transportation (3)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.